Naoto Ueno, MD, PhD
Enriched profileDirector, University of Hawaiʻi Cancer Center; Professor, Department of Medicine, John A. Burns School of Medicine; Full Member, Cancer Biology Program (Translational and Clinical Research) · University of Hawaiʻi Cancer Center
Naoto Ueno is Director, University of Hawaiʻi Cancer Center; Professor, Department of Medicine, John A. Burns School of Medicine; Full Member, Cancer Biology Program (Translational and Clinical Research) at University of Hawaiʻi Cancer Center. OpenAlex indexes 1,442 publications with 49,693 citations (h-index 98); ClinicalTrials.gov lists 21 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Medical Oncology profiles in the findmyKOL directory.
Data verified 7 Sept 2026
Overview
Updated 14 Oct 2026
Naoto T. Ueno, M.D. PhD, is Director, University of Hawaiʻi Cancer Center. The public record shows 1,442 publications with 49,693 citations (h-index 98), centered on Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Advanced Breast Cancer Therapies. It also documents an investigator role on 21 registered clinical trials, industry payments reported by 26 companies, 4 NIH-funded awards (2019–2026).
- Most recent indexed publication: 2026 · British journal of cancer
- Top research focus: Breast Cancer Treatment Studies
- 21 registered trials on ClinicalTrials.gov
- Open Payments reporting from 26 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 70 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 406.
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uhcancercenter.org ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 21 registered studies on ClinicalTrials.gov. The most recent:
- Droplet-BC Screening Test for the Detection of Breast Cancer, the DROPLET-BC Study
Sponsor: Preferred Medicine, Inc
- Harvest of CTCs From MBC Patients Using the Parsortix™ PC1 System
Sponsor: Angle plc
- Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
Sponsor: OncoTherapy Science, Inc.
Industry payments
Updated 14 Oct 2026
26 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Chugai Pharmaceutical Co., Ltd.Program year20257 payments$26,930openpaymentsdata.cms.gov ↗
- AstraZeneca Pharmaceuticals LPProgram year20254 payments
- Caris MPI, Inc.Program year20252 payments
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Phenothiazine100%Prochlorperazine Maleate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 14 Oct 2026
4 NIH research awards on record, funded 2019–2026 per NIH RePORTER. The latest:
- CD44 splice variants as novel antibody-targets for advanced breast cancer
University of Texas at Austin
FY2026$668,878R01CA310174 - Developing a novel combination immunotherapy for triple-negative breast cancer
University of Hawaii at Manoa
FY2026$650,749R01CA278056
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- ATR inhibition potentiates the antitumor efficacy of HER3-DXd in HER3-positive/HR-positive breast cancer by increasing DNA damage.
British journal of cancer
Article2026 - Understanding and Overcoming Antibody-Drug Conjugate Resistance: Biological Mechanisms and Emerging Analytical Frameworks in Breast Cancer.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Review2026 - Payload Diversification Overcomes Resistance and Guides Sequential Antibody-Drug Conjugate Therapy in Breast Cancer.
Clinical cancer research
Article2026
Most-cited works
by citation count (OpenAlex)- 01Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer2,561 citations2022
- 02Landscape of somatic mutations in 560 breast cancer whole-genome sequences2,352 citations2016
- 03
- 05Role of epidermal growth factor receptor in breast cancer803 citations2012
Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/naoto-ueno-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Facebook
facebook.com/ntueno
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - LinkedIn
linkedin.com/in/naoto-ueno-28a34539
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Google Scholar
scholar.google.com/citations
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholar.google.com ↗ - ResearchGate
researchgate.net/profile/Naoto-Ueno
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - X / Twitter
x.com/teamoncology
- Instagram
instagram.com/naotoueno
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →instagram.com ↗
Mentions by others
where others cite or feature them- Other
en.wikipedia.org/wiki/Naoto_Ueno
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗ - Other
bcrf.org/researchers/naoto-t-ueno
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bcrf.org ↗ - Other
uhcancercenter.org/ueno-naoto
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uhcancercenter.org ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - Pub.orcid.org
X (Twitter) handle: @teamoncology, listed as external researcher-URL on ORCID record (created/last-modified 2024-11-11) …
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pub.orcid.org ↗ - LinkedIn
LinkedIn profile: Naoto Ueno - University of Hawaiʻi Cancer Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - Facebook
Facebook profile under name Naoto T Ueno
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →facebook.com ↗ - Pub.orcid.org
SciProfiles ID 971210 (MDPI author profile system), listed as an ORCID external identifier, likely underlies the previously-unconfirmed MDPI 'Cancers' journal Section Editor-in-Chief claim …
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pub.orcid.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pittmed.pitt.edu ↗
- MD
Wakayama Medical College, Japan
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uhcancercenter.org ↗ - PhD in Cancer Biology
The University of Texas Graduate School of Biomedical Sciences
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uhcancercenter.org ↗ - Clinical Fellowship in Medical Oncology and Blood and Marrow Transplantation
The University of Texas MD Anderson Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uhcancercenter.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗
- Board Certified
Medical Oncology / Internal Medicine (per self-reported Facebook post: "board-certified in internal medicine for 30 years" …
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hawaii.edu ↗
- Founder
Japan TeamOncology Program (J-TOP), founded 2002 as an MD Anderson-affiliated multidisciplinary breast-oncology capacity-building initiative in Japan/Asia; program now marking 22+ years
2002verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →connection.asco.org ↗ - Professor
Department of Medicine, John A. Burns School of Medicine, University of Hawaiʻi at Mānoa
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uhcancercenter.org ↗ - Full Member
Cancer Biology Program (Translational and Clinical Research), UH Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uhcancercenter.org ↗ - Founder
CancerX (cancer advocacy initiative in Japan)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uhcancercenter.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uhcancercenter.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uhcancercenter.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uhcancercenter.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uhcancercenter.org ↗
Secondary affiliations
appointments beyond the home institution- Former Professor of Medicine
Executive Director of the Morgan Welch Inflammatory Breast Cancer Research Program & Clinic, and Section Chief of Translational Breast Cancer Research …
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uhcancercenter.org ↗ - Visiting Professor
Keio University (Japan)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
- Staff physician
Hawaii Pacific Health and Queen's Health System (per Doximity and Hawaii Pacific Health provider directory, independently corroborating the Wikipedia claim above)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hawaiipacifichealth.org ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uhcancercenter.org ↗
- The ASCO Post
"Living a Full Life" interview series feature: "New Director of the University of Hawaii Cancer Center, Naoto T. Ueno, MD, PhD, FACP, Is Also a Two-Time Cancer Survivor"
2024verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
- Pitt Med Magazine (University of Pittsburgh) feature: "Expert. Survivor: Naoto Ueno"
profile on his cancer journey and training under John Kirkwood
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pittmed.pitt.edu ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncodaily.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cco.amegroups.org ↗
- ASCO Connection feature: "Transforming Cancer Care in Asia: 22 Years of the Japan TeamOncology Program (J-TOP)"
corroborates his founding role of J-TOP
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →connection.asco.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Gabriel Hortobagyi, MD
The University of Texas MD Anderson Cancer Center
Eric Winer, MD
Yale School of Medicine
Hope Rugo, MD
City of Hope
Dennis Slamon, MD
University of California, Los Angeles